WebMar 16, 2024 · Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle … WebSOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 31, 2024 it granted stock …
Cytokinetics, Incorporated (NASDAQ:CYTK) Analysts Just Cut …
WebApr 6, 2024 · The stock price has decreased by -13.64% in the last 52 weeks. The beta is 0.85, so Cytokinetics's price volatility has been lower than the market average. Beta (1Y) WebClose price at the end of the last trading day (Wednesday, 1st Mar 2024) of the CYTK stock was $43.11. This is 0.577% less than the trading day before Tuesday, 28th Feb 2024. During the day the stock fluctuated 2.40% from a day low at $42.86 to a day high of $43.89. henry ford vascular surgery
Cytokinetics (CYTK) Price To Free Cash Flow - Zacks.com
WebJan 2, 2024 · Cytokinetics gets plenty of support on Wall Street; Its Strong Buy consensus rating is based on 11 recent reviews that include 10 Buys over just 1 Hold. The shares are selling for $45.82 and their $63.18 … WebFeb 28, 2024 · Cytokinetics Stock Up 0.4 %. Shares of CYTK opened at $42.98 on Tuesday. Cytokinetics, Incorporated has a 52 week low of $33.10 and a 52 week high of $55.80. The firm has a market cap of $4.07 billion, a P/E ratio of -13.60 and a beta of 0.90. The firm's 50-day simple moving average is $43.66 and its 200 day simple moving … Web1 day ago · See the latest Cytokinetics Inc stock price (NASDAQ:CYTK), related news, valuation, dividends and more to help you make your investing decisions. henry ford vascular surgery fellowship